Browse by author
Lookup NU author(s): Professor Quentin AnsteeORCiD, Professor Ann DalyORCiD, Professor Chris Day
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Excess alcohol consumption with consequent alcoholic liver disease (ALD) is a common cause of liver dysfunction and liver-related mortality worldwide. However, although the majority of heavy drinkers will develop steatosis, only a minority progress to advanced liver disease and cirrhosis. Thus, ALD is a complex disease where subtle interpatient genetic variations and environmental factors interact to determine disease progression. One genome-wide association study specifically addressing geneticmodifiers of ALD has been published. However, most of our understanding is based on studies conducted on nonalcoholic fatty liver disease. Translation of candidates from these studies into ALD has established a role for variants in genes including PNPLA3 and potentially TM6SF2 across the disease spectrum from steatosis, through cirrhosis to hepatocellular carcinoma. Here the authors review the current status of the field with a particular focus on recent advances.
Author(s): Anstee QM, Daly AK, Day CP
Publication type: Review
Publication status: Published
Journal: Seminars in Liver Disease
Year: 2015
Volume: 35
Issue: 4
Pages: 361-374
Print publication date: 01/11/2015
Acceptance date: 01/01/1900
ISSN (print): 0272-8087
ISSN (electronic): 1098-8971
Publisher: THIEME MEDICAL PUBL INC
URL: http://dx.doi.org/10.1055/s-0035-1567832
DOI: 10.1055/s-0035-1567832